6
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Complement C3 activation is a characteristic finding in membranoproliferative GN (MPGN). This activation can be caused by immune complex deposition or an acquired or inherited defect in complement regulation. Deficiency of complement factor H has long been associated with MPGN. More recently, heterozygous genetic variants have been reported in sporadic cases of MPGN, although their functional significance has not been assessed. We describe a family with MPGN and acquired partial lipodystrophy. Although C3 nephritic factor was shown in family members with acquired partial lipodystrophy, it did not segregate with the renal phenotype. Genetic analysis revealed a novel heterozygous mutation in complement factor H (R83S) in addition to known risk polymorphisms carried by individuals with MPGN. Patients with MPGN had normal levels of factor H, and structural analysis of the mutant revealed only subtle alterations. However, functional analysis revealed profoundly reduced C3b binding, cofactor activity, and decay accelerating activity leading to loss of regulation of the alternative pathway. In summary, this family showed a confluence of common and rare functionally significant genetic risk factors causing disease. Data from our analysis of these factors highlight the role of the alternative pathway of complement in MPGN.

          Related collections

          Author and article information

          Journal
          J. Am. Soc. Nephrol.
          Journal of the American Society of Nephrology : JASN
          American Society of Nephrology (ASN)
          1533-3450
          1046-6673
          Nov 2014
          : 25
          : 11
          Affiliations
          [1 ] Institutes of Genetic Medicine, and.
          [2 ] Edinburgh Biomolecular Nuclear Magnetic Resonance Unit, and.
          [3 ] The Renal Unit, Aberdeen Royal Infirmary, Aberdeen, United Kingdom; and.
          [4 ] Medical Research Council Centre for Inflammation Research, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom;
          [5 ] Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom;
          [6 ] Cardiff Institute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.
          [7 ] Institutes of Genetic Medicine, and david.kavanagh@ncl.ac.uk.
          Article
          ASN.2013070732
          10.1681/ASN.2013070732
          4214516
          24722444
          350e36b0-70fa-4502-abe6-64f7e575e0f0
          History

          complement,immunology,membranoproliferative GN (MPGN)

          Comments

          Comment on this article